ICMR plans to examine whether novel coronavirus strain in India changed structure

ICMR plans to examine whether novel coronavirus strain in India changed structure


  • Post By : Kumar Jeetendra

  • Source: PTI

  • Date: 02 May,2020

The Indian Council of Medical Research (ICMR) is wanting to consider whether the novel coronavirus strain in India has experienced change while spreading inside the nation in the course of the most recent two months.

As indicated by a senior researcher of the nation’s pinnacle wellbeing research body, deciding if the SARS-CoV2 strain has changed structure will help in guaranteeing the adequacy of a potential immunization.

“The investigation will likewise show whether it has become increasingly destructive and expanded transmission ability.”

Tests will be gathered from COVID-19 patients to contemplate whether the novel coronavirus strain has transformed or not, he said.

In any case, the examination can start once the lockdown is lifted since at present there are challenges associated with transportation of tests from various states and Union Territories, researchers said.

According to Global Initiative on Sharing All Influenza Data (GISAID), so far the most extreme distinction in the novel coronavirus strain in India has been seen as between 0.2 to 0.9 percent when contrasted with the strains in different nations, another researcher said.

GISAID, which advances universal sharing of all flu infection arrangements and related clinical and epidemiological information, has more than 7,000 complete genome successions of SARS-CoV2 kept by different labs over the existence where they have characterized the infection dependent on their transformations.

There are chances that individuals showing up in India from various nations are bringing different strains of the infection.

Three strains of the infection have been followed in India up until now. One was from Wuhan, and the other two from Italy and Iran. The arrangement of the coronavirus strain from Iran was like that of China.

“It will require some investment for us to know the transcendent semi types of the novel coronavirus in the nation. Be that as it may, changes are not liable to make potential immunizations insufficient, as all sub-sorts of the infection have similar catalysts. Likewise, it has been in India for a quarter of a year and it doesn’t change extremely quick,” Head of Epidemiology and Communicable Diseases at ICMR Dr Raman R Gangakhedkar had said before.

Six Indian organizations are taking a shot at an immunization for COVID-19, joining the worldwide race to locate a preventive for the dangerous contamination spreading quickly over the world.

Almost 70 ‘immunization competitors’ are being tried and in any event three have moved to the human clinical preliminary stage, however an antibody for the novel coronavirus is probably not going to be prepared for mass use before 2021.

India has likewise worked together with WHO’s multi-nation “solidarity trial” for creating potential medicines and medications for COVID-19.

The loss of life due to COVID-19 rose to 1,218 and the quantity of cases moved to 37,336 in the nation on Saturday, as indicated by the Union Health Ministry The quantity of dynamic COVID-19 cases remained at 26,167, while 9,950 individuals have recuperated and one patient has relocated.

About Author